MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration
Advanced Drug Delivery Reviews · 2024-04 · 207 · 115214
DOI: 10.1016/j.addr.2024.115214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-04. Verfasst von Hussein H Genedy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR1229, Nantes, France; Univ Angers, INSERM, CNRS, MINT, SF…. Hauptthemen laut MEDLINE: MicroRNAs, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 241 Literaturangaben. Gefördert von: French National Research Agency, Région Pays de la Loire.
Abstract (Originalsprache)
Low back pain stands as a pervasive global health concern, afflicting almost 80% of adults at some point in their lives with nearly 40% attributable to intervertebral disc degeneration (IVDD). As only symptomatic relief can be offered to patients there is a dire need for innovative treatments.Given the accumulating evidence that multiple microRNAs (miRs) are dysregulated during IVDD, they could have a huge potential against this debilitating condition. The way miRs can profoundly modulate signaling pathways and influence several cellular processes at once is particularly exciting to tackle this multifaceted disorder. However, miR delivery encounters extracellular and intracellular biological barriers. A promising technology to address this challenge is the vectorization of miRs within nanoparticles, providing both protection and enhancing their uptake within the scarce target cells of the degenerated IVD. This comprehensive review presents the diverse spectrum of miRs' connection with IVDD and demonstrates their therapeutic potential when vectorized in nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR1229, Nantes, France; Univ Angers, INSERM, CNRS, MINT, SFR ICAT, F-49000 Angers, France.
- Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR1229, Nantes, France.
- Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR1229, Nantes, France; Department of Diagnostic Imaging, CRIP, ONIRIS, College of Veterinary Medicine, Food Science and Engineer…
- Univ Angers, INSERM, CNRS, MINT, SFR ICAT, F-49000 Angers, France.
- Univ Angers, INSERM, CNRS, MINT, SFR ICAT, F-49000 Angers, France; Institut Universitaire de France (IUF), France. Electronic address: elise.lepeltier@univ-angers.fr.
Förderung
- French National Research Agency
- Région Pays de la Loire
Zitieren
APA
Genedy, H. H., Humbert, P., Laoulaou, B., Le Moal, B., Fusellier, M., Passirani, C., Le Visage, C., Guicheux, J., Lepeltier, É., & Clouet, J. (2024). MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration. Advanced Drug Delivery Reviews, 207, 115214. https://doi.org/10.1016/j.addr.2024.115214
Vancouver
Genedy HH, Humbert P, Laoulaou B, Le Moal B, Fusellier M, Passirani C, et al. MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration. Advanced Drug Delivery Reviews. 2024;207:115214. doi:10.1016/j.addr.2024.115214
BibTeX
@article{Genedy2024,
author = {Genedy, Hussein H and Humbert, Paul and Laoulaou, Bilel and Le Moal, Brian and Fusellier, Marion and Passirani, Catherine and Le Visage, Catherine and Guicheux, Jérôme and Lepeltier, Élise and Clouet, Johann},
title = {MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {207},
pages = {115214},
doi = {10.1016/j.addr.2024.115214}
}
EUVIMED